Alpha4 integrins as therapeutic targets in autoimmune disease
- PMID: 12510047
- DOI: 10.1056/NEJMe020157
Alpha4 integrins as therapeutic targets in autoimmune disease
Comment on
-
A controlled trial of natalizumab for relapsing multiple sclerosis.N Engl J Med. 2003 Jan 2;348(1):15-23. doi: 10.1056/NEJMoa020696. N Engl J Med. 2003. PMID: 12510038 Clinical Trial.
-
Natalizumab for active Crohn's disease.N Engl J Med. 2003 Jan 2;348(1):24-32. doi: 10.1056/NEJMoa020732. N Engl J Med. 2003. PMID: 12510039 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical